insights_auto
为什么 DBV 上涨了 7.34%?
深入探索chevron_right
DBV:EPA
DBV Technologies SA
€1.71
arrow_upward
+7.34%(+0.12) 1 天
10月20日, GMT+2 17:35:07 · EUR
search
所有股票代码
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 DBV 生成关键数据洞见…
开盘价
€1.60
最高价
€1.71
最低价
€1.58
市值
5.41亿
平均成交量
110.93万
成交量
132.10万
52 周最高价
€4.50
52 周最低价
€1.55
每股收益
-€0.64
流通股数
3.14亿
员工人数
170
开盘价
€1.60
最高价
€1.71
最低价
€1.58
市值
5.41亿
平均成交量
110.93万
成交量
132.10万
52 周最高价
€4.50
52 周最低价
€1.55
每股收益
-€0.64
流通股数
3.14亿
员工人数
170
新闻报道
来自网络来源和新闻合作伙伴
Foreign Policy Journal
·
12分钟前
Super Micro Computer (NASDAQ: SMCI) Lands Over $60 Billion In Orders As Legal Clouds Raise Discount Questions
Benzinga
·
1小时前
Quantum BioPharma (NASDAQ: QNTM) Featured in Men’s Fitness Article Examining Unbuzzd Clinical Trial Resul
Yahoo Finance
·
26分钟前
Unpacking Q2 Earnings: Zoom (NASDAQ:ZM) In The Context Of Other Video Conferencing Stocks
Seeking Alpha
·
49分钟前
Energy Stocks Lead This Year, But Tech Still Drives The S&P 500
资料
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration. Wikipedia
DBV Technologies SA简介